Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Gastroenterologie Clinique Et Biologique|October 12, 2010
Transcatheter local thrombolysis in patients with extensive TIPS thrombosisJ Dumortier, T Walter, O Guillaud, et al.Transplantation Proceedings|September 14, 2010
Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experienceJ Dumortier, O Guillaud, G Pittau, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 18, 2007
Rejection under alpha interferon therapy in liver transplant recipientsT Walter, J Dumortier, O Guillaud, et al.Transplantation Proceedings|August 20, 2013
Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantationO Guillaud, K C Gurram, M Puglia, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2016
Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcomeJ Dumortier, O Guillaud, A Bosch, et al.Gastroenterologie Clinique Et Biologique|August 3, 2010
Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complexJ Dumortier, O Guillaud, T Walter, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 25, 2005
Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapyE Khattab, I Chemin, I Vuillermoz, et al.United European Gastroenterology Journal|August 18, 2017
Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatmentsT Walter, C Zhenzhen Wang, O Guillaud, et al.Diagnostic and Interventional Imaging|December 15, 2015
Shear wave elastography: An accurate technique to stage liver fibrosis in chronic liver diseasesA Guibal, G Renosi, A Rode, et al.Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.Pageof 2